Feasibility and impact of a monoclonal antibody infusion program in reaching vulnerable underserved communities
Description
The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted Black, indigenous, and people of color (BIPOC). Equitable access to therapeutics is key to addressing health disparities. We established a monoclonal infusion program in
